According to Malawi guidelines the APRI score should not be used for patients with very high AST or ALT levels (≥ 300 U/l) as these levels may be more indicative of acute than chronic hepatitis B. 10 (9.0%) patients had such high APRI scores. The gene discussed is GPT; the disease is chronic hepatitis B virus infection.